RECRUITINGOBSERVATIONAL
Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation
Real-world Experience of Catheter Ablation for the Treatment of Symptomatic ParoxysmaL and Persistent Atrial Fibrillation Using Novel CARTO Technologies: REAL AF Registry
About This Trial
The primary purpose of this registry is to obtain real-world clinical experience of Paroxysmal (PAF) and Persistent (PsAF) Atrial Fibrillation ablation radiofrequency (RF) technologies. Data from the registry will be used to assess clinical outcomes, including procedural efficiency, safety, and long-term, effectiveness of catheter ablation with novel RF technologies in PAF and PsAF patients.
Who May Be Eligible (Plain English)
Who May Qualify:
- Symptomatic Paroxysmal (AF episode terminate spontaneously within 7 days) or Persistent (AF sustained beyond 7 days) who, in the opinion of the investigator, are candidates for ablation for AF
- 18 years of age or older
- De Novo ablation procedure unless it is a repeat for a patient whose index procedure is also in the registry
- Able and willing to participate in baseline and follow up evaluations for the full length of the registry
- Willing and able to provide willing to sign a consent form, if applicable
Who Should NOT Join This Trial:
- Enrolled in an investigational drug or device clinical trial, or any trial that dictates the treatment plan
- Long-standing persistent AF (AF greater than one year's duration)
- Having a repeat ablation, unless the subject's index ablation procedure is also included in the registry
- In the opinion of the investigator, any known contraindication to an ablation procedure
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Symptomatic Paroxysmal (AF episode terminate spontaneously within 7 days) or Persistent (AF sustained beyond 7 days) who, in the opinion of the investigator, are candidates for ablation for AF
* 18 years of age or older
* De Novo ablation procedure unless it is a repeat for a patient whose index procedure is also in the registry
* Able and willing to participate in baseline and follow up evaluations for the full length of the registry
* Willing and able to provide informed consent, if applicable
Exclusion Criteria:
* Enrolled in an investigational drug or device clinical trial, or any trial that dictates the treatment plan
* Long-standing persistent AF (AF greater than one year's duration)
* Having a repeat ablation, unless the subject's index ablation procedure is also included in the registry
* In the opinion of the investigator, any known contraindication to an ablation procedure
Treatments Being Tested
DEVICE
Catheter ablation
Ablation RF technologies (e.g., THERMOCOOL SMARTTOUCH®, THERMOCOOL SMARTTOUCH® SF).
Locations (20)
University of Alabama at Birmingham
Birmingham, Alabama, United States
Grandview Medical Center
Birmingham, Alabama, United States
Cardiology Associates of Mobile
Mobile, Alabama, United States
Valley Heart Rhythm Specialists
Chandler, Arizona, United States
Arrhythmia Research Group
Jonesboro, Arkansas, United States
Keck School of Medicine
Los Angeles, California, United States
Santa Barbara Cottage Hospital
Santa Barbara, California, United States
Community Memorial Hospital
Ventura, California, United States
University HealthCare Alliance
Walnut Creek, California, United States
The Medical Center of Aurora
Aurora, Colorado, United States
Colorado Heart and Vascular
Golden, Colorado, United States
South Denver Cardiology
Littleton, Colorado, United States
Ascension St. Vincent's
Jacksonville, Florida, United States
HCA Florida Mercy Hospital
Miami, Florida, United States
Naples Community Hospital
Naples, Florida, United States
Ascension Sacred Heart
Pensacola, Florida, United States
Sarasota Memorial Hospital
Sarasota, Florida, United States
Baycare Health System
Winter Haven, Florida, United States
Piedmont Healthcare
Atlanta, Georgia, United States
Memorial Health University Medical Center
Savannah, Georgia, United States